a month ago
XENE
AnalystsBenjamin BurnettBenjamin Burnett's Stock Forecasts
AnalystsBenjamin Burnett
Analyst Ranking
Bottom 5%
#5295 out of 5549 analysts
Average Return
-4.2%
Win Rate
34%43 out of 128
Risk vs Reward
Poor
Good
Benjamin Burnett's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Gracell Biotechnologies IncGRCL | +271.38% | $2.76 | $10.25 | 2023-10-19 - 2024-02-21 | Strong Buy |
Revolution Medicines IncRVMD | +189.26% | $33.62 | $97.25 | 2025-04-01 - 2026-03-31 | Strong Buy |
Revolution Medicines IncRVMD | +161.39% | $39.08 | $102.15 | 2025-02-27 - 2026-02-26 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +148.33% | $15.91 | $39.51 | 2025-09-03 - 2026-04-20 | Strong Buy |
Cti Biopharma CorpCTIC | +134.68% | $2.22 | $5.21 | 2021-05-06 - 2022-05-05 | Strong Buy |
Benjamin Burnett Analyst Color
Get additional color on Benjamin Burnett's coverage of popular stocks
2 months ago
RARE
3 months ago
PTCT
3 months ago
AXSM
3 months ago
INSM
3 months ago
PTCT
3 months ago
INSM
5 months ago
WVE
6 months ago
MNKD
7 months ago
INSM
3 years ago
IRON
Benjamin Burnett's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Helus Pharma IncHELP | 2 | Strong Buy | $22.00 | +105.42% | Maintains | 8 days ago |
Rapport Therapeutics IncRAPP | 3 | Strong Buy | $50.00 | +106.53% | Maintains | 9 days ago |
Liquidia CorpLQDA | 6 | Hold | $33.00 | -26.65% | Maintains | 16 days ago |
Xenon Pharmaceuticals IncXENE | 6 | Strong Buy | $64.00 | +70.48% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 5 | Strong Buy | $18.00 | +7.27% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 6 | Strong Buy | $109.00 | +69.10% | Maintains | 3 months ago |
Definium Therapeutics IncDFTX | 2 | Strong Buy | $72.00 | +89.67% | Maintains | 3 months ago |
Axsome Therapeutics IncAXSM | 6 | Strong Buy | $256.00 | +78.46% | Maintains | 3 months ago |
Amphastar Pharmaceuticals IncAMPH | 3 | Hold | $20.00 | -25.73% | Maintains | 3 months ago |
Praxis Precision Medicines IncPRAX | 3 | Hold | $362.00 | +25.42% | Maintains | 3 months ago |
Insmed IncINSM | 7 | Strong Buy | $169.00 | +51.45% | Maintains | 3 months ago |
Mannkind CorpMNKD | 6 | Strong Buy | $13.00 | +271.43% | Maintains | 3 months ago |
Keros Therapeutics IncKROS | 3 | Strong Buy | $18.00 | +58.45% | Maintains | 3 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $44.00 | +104.65% | Initiates Coverage On | 3 months ago |
Compass Pathways PLCCMPS | 1 | Hold | $13.00 | +6.64% | Initiates Coverage On | 3 months ago |
Alkermes PLCALKS | 6 | Strong Buy | $65.00 | +43.27% | Maintains | 4 months ago |
Wave Life Sciences IncWVE | 5 | Strong Buy | $14.00 | +285.67% | Maintains | 5 months ago |
United Therapeutics CorpUTHR | 5 | Strong Buy | $738.00 | +24.34% | Upgrades | 6 months ago |
Centessa Pharmaceuticals PLCCNTA | 4 | Hold | $42.00 | +3.70% | Downgrades | 6 months ago |
Savara IncSVRA | 1 | Strong Buy | $9.00 | +81.82% | Maintains | 10 months ago |
Avadel Pharmaceuticals PLCAVDL | 3 | Hold | $22.50 | +3.97% | Maintains | a year ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $64.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Crispr Therapeutics AgCRSP | 7 | Hold | $49.00 | N/A | Maintains | 2 years ago |
Disc Medicine IncIRON | 7 | Strong Buy | $94.00 | N/A | Maintains | 2 years ago |
Repare Therapeutics IncRPTX | 5 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
Arcellx IncACLX | 5 | Strong Buy | $122.00 | N/A | Maintains | 2 years ago |
Beam Therapeutics IncBEAM | 2 | Strong Buy | $69.00 | N/A | Maintains | 2 years ago |
Ideaya Biosciences IncIDYA | 7 | Strong Buy | $68.00 | N/A | Maintains | 2 years ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | $86.00 | N/A | Initiates Coverage On | 2 years ago |
Cabaletta Bio IncCABA | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Precigen IncPGEN | 3 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Allogene Therapeutics IncALLO | 4 | Hold | $4.60 | N/A | Maintains | 2 years ago |
Atara Biotherapeutics IncATRA | 4 | Hold | $57.50 | N/A | Maintains | 3 years ago |
Kinnate Biopharma IncKNTE | 5 | Hold | $2.59 | N/A | Maintains | 3 years ago |
Gracell Biotechnologies IncGRCL | 2 | Hold | $10.25 | N/A | Downgrades | 3 years ago |
Mirati Therapeutics IncMRTX | 6 | Hold | $59.00 | N/A | Downgrades | 3 years ago |
Iovance Biotherapeutics IncIOVA | 9 | Strong Buy | $25.00 | N/A | Reiterates | 3 years ago |
Effector Therapeutics IncEFTR | 4 | Strong Buy | $175.00 | N/A | Upgrades | 3 years ago |
Cti Biopharma CorpCTIC | 2 | Hold | $9.10 | N/A | Downgrades | 3 years ago |
Neurogene IncNGNE | 2 | Hold | $4.50 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Genocea Biosciences IncGNCAQ | 1 | Hold | $0.16 | N/A | Downgrades | 5 years ago |
Precision Biosciences IncDTIL | 2 | Strong Buy | $780.00 | N/A | Maintains | 5 years ago |
Nektar TherapeuticsNKTR | 2 | Strong Buy | $360.00 | N/A | Upgrades | 5 years ago |
Sangamo Therapeutics IncSGMO | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 6 years ago |
Bluebird Bio IncBLUE | 3 | Strong Buy | $1,400.00 | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.